Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial

Invasive fungal disease (IFD) confers a substantial risk for morbidity and mortality to immunocompromised patients. Invasive aspergillosis (IA) is the most common IFD caused by moulds but the prevalence of other rare mould diseases, such as mucormycosis, hyalohyphomycosis and phaeohyphomycosis, may...

Descripción completa

Detalles Bibliográficos
Autores principales: Perfect, John R., Cornely, Oliver A., Heep, Markus, Ostrosky-Zeichner, Luis, Mullane, Kathleen M., Maher, Rochelle, Croos-Dabrera, Rodney, Lademacher, Christopher, Engelhardt, Marc, Chen, Caroline, Marty, Francisco M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490690/
https://www.ncbi.nlm.nih.gov/pubmed/29570857
http://dx.doi.org/10.1111/myc.12769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490690/
https://www.ncbi.nlm.nih.gov/pubmed/29570857
http://dx.doi.org/10.1111/myc.12769

Ejemplares similares